Kyle Tarantino is currently the Director of Medicinal Chemistry at Modifi Bio, where Kyle has been working since November 2021. Prior to this, Kyle held positions at Pfizer as a Principal Scientist in Internal Medicine Medicinal Chemistry, and at Princeton University as a Senior Scientist in the Knowles Lab. Kyle completed their PhD in Chemistry at Princeton University in 2016 after obtaining their BS in Chemistry from California Polytechnic State University-San Luis Obispo in 2008.
November, 2021 - present
AI Scientist at Ekkel AI
Research Scientist at Mazumdar Shaw Medical Foundation (MSMF)
Research Resources Team Member at Australian Medical Students' Association
Data Science Vice President at PS AI Labs
Co-founder & CEO At 369 Labs | Beat Energy at Embertec
Access the worlds's biggest network of public org charts
Learn more